1. Introduction
Rectal cancer is a malignant tumor arising from the epithelial lining of the rectum, the terminal part of the large intestine. It accounts for a significant proportion of colorectal cancers and is a major cause of cancer-related morbidity and mortality worldwide. Early detection and multimodal management have substantially improved survival outcomes.
2. Types of Rectal Cancer
Rectal cancer is classified based on histology and clinical behavior:
- Adenocarcinoma
- Mucinous adenocarcinoma
- Produces excessive mucin
- Often associated with a poorer prognosis
- Signet ring cell carcinoma
- Aggressive, rare subtype
- Seen in younger patients
- Neuroendocrine tumors (NETs)
- Arise from neuroendocrine cells
- Usually slow-growing
- Squamous cell carcinoma (rare)
- More common in the anal canal than the rectum
3. Pathogenesis
Rectal cancer develops through a multistep process involving genetic and environmental factors:
- Adenoma–carcinoma sequence
- Accumulation of genetic mutations:
- APC gene mutation (early event)
- KRAS activation
- TP53 inactivation
- Microsatellite instability (MSI) in some cases
- Risk factors:
- Chronic inflammatory bowel disease (IBD)
- Low-fiber, high-fat diet
- Smoking and alcohol
- Obesity and a sedentary lifestyle
- Family history and hereditary syndromes (FAP, Lynch syndrome)
4. Laboratory Diagnosis
Laboratory and diagnostic evaluation includes:
A. Screening and Initial Tests
B. Endoscopic Diagnosis
C. Histopathology
- Confirmation of malignancy
- Tumor grading and staging
D. Imaging and Staging
- MRI pelvis (preferred for local staging)
- CT scan (chest, abdomen, pelvis) for metastasis
- Endorectal ultrasound (ERUS)
E. Tumor Markers
5. Treatment
Management depends on tumor stage, location, and patient factors:
A. Surgery
- Low anterior resection (LAR)
- Abdominoperineal resection (APR)
- Total mesorectal excision (TME) is the standard approach
B. Chemotherapy
- Neoadjuvant or adjuvant therapy
- Common regimens:
- FOLFOX
- CAPOX
- 5-Fluorouracil–based therapy
C. Radiotherapy
- Preoperative (neoadjuvant) radiotherapy reduces local recurrence
- Often combined with chemotherapy (chemoradiation)
D. Targeted and Immunotherapy
- EGFR inhibitors (e.g., cetuximab) in selected cases
- Immunotherapy in MSI-high tumors
6. Prevention
Preventive strategies focus on risk reduction and early detection:
- Regular screening colonoscopy
- High-fiber, low-fat diet
- Increased intake of fruits and vegetables
- Avoid smoking and excessive alcohol use
- Maintain a healthy body weight
- Physical activity
- Surveillance in high-risk individuals
7. Keynotes
- Rectal cancer is a major subtype of colorectal cancer with distinct management.
- Adenocarcinoma is the most common histological type.
- MRI pelvis is crucial for staging and treatment planning.
- Multimodal therapy (surgery + chemoradiation) improves outcomes.
- Early detection significantly increases survival.
- Regular screening is the cornerstone of prevention.
Further Readings
- https://emedicine.medscape.com/article/281237-overview
- https://www.cancer.org/cancer/types/colon-rectal-cancer/about/what-is-colorectal-cancer.html
- https://clsjournal.ascls.org/content/ascls/early/2024/09/18/ascls.2022003206.full.pdf
- https://www.mdpi.com/2079-4991/12/1/169
- https://www.ncbi.nlm.nih.gov/books/NBK493202
- https://surgicaloncology.ucsf.edu/condition/rectal-cancer
- https://www.mdpi.com/2072-6694/17/4/588
- https://www.gastroconsa.com/colorectal-cancer-screening-guidelines-for-2025
- https://pmc.ncbi.nlm.nih.gov/articles/PMC9972668
- https://pmc.ncbi.nlm.nih.gov/articles/PMC4431429
- https://www.sciencedirect.com/science/article/pii/S014067362400360X
- https://pmc.ncbi.nlm.nih.gov/articles/PMC7768867
- https://pmc.ncbi.nlm.nih.gov/articles/PMC4312646